Inigo Montes

Inigo is Business Development Director at tranScrip and has a proven commercial track record in the pharmaceutical and biopharmaceutical Contract Research Organisation (CRO) industry having held senior Business Development roles in LGC, Almac Diagnostics and more recently QPS. Inigo has approximately 12 years’ experience in Commercial Business Development with extensive experience in the fields of Phase I clinical trials, Companion Diagnostics, DMPK, toxicology, GCP and GLP Bioanalytical Services (PK, PD, Immunogenicity), GMP and CMC Analytical Services.

Inigo holds a degree and a PhD in Biochemistry and Biomedical sciences and prior to working in CROs he has worked in Aventis Pharma (now Sanofi), Oxford Medistress and Oxford BioTherapeutics as a scientist and project manager.